Problems in the development of target-based drugs Nagahiro SaijoTomohide TamuraKazuto Nishio Pages: S43 - S45
Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies William G. NelsonJonathan W. SimonsFray F. Marshall Pages: S67 - S72
Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer Kerry A. ChesterAstrid MayerRichard H. J. Begent Pages: S8 - S12
Human CD8 and CD4 T cell epitopes of epithelial cancer antigens Noriyuki SatoYuki NabetaH. Ikeda Pages: S86 - S90
Recombinant antibodies against ganglioside expressed on tumor cells Nobuo HanaiKazuyasu NakamuraKenya Shitara Pages: S13 - S17
An immunotherapeutic approach to treatment of breast cancer: focus on trastuzumab plus paclitaxel Teresa GilewskiAndrew SeidmanBreast Cancer Medicine Service Pages: S23 - S26
Exploitation of the B cell repertoire for the identification of human tumor antigens Michael Pfreundschuh Pages: S3 - S7
SEREX analysis of gastric cancer antigens Yuichi ObataToshitada TakahashiLloyd J. Old Pages: S37 - S42
Melanoma vaccines: the paradox of T cell activation without clinical response Mai-Britt NielsenFrancesco M. Marincola Pages: S62 - S66
Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells Kenzaburo TaniYukoh NakazakiShigetaka Asano Pages: S73 - S76
Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients Vincenzo Cerundolo Pages: S83 - S85
Development of a cancer vaccine: peptides, proteins, and DNA Hiroshi ShikuLijie WangHideo Nakamura Pages: S77 - S82
Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates Eric L. Sievers Pages: S18 - S22
Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer Junichi SakamotoHiroshi KojimaH. Suzuki Pages: S27 - S32
Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease Ligia da CostaChristoph RennerMichael Pfreundschuh Pages: S33 - S36
The critical role of Th1-dominant immunity in tumor immunology Takashi NishimuraMinoru NakuiShinichiro Nishimura Pages: S52 - S61